SREBF1 and fatty liver disease: Scopoletin (0.05% w/w) effectively attenuated alcohol-induced hepatic steatosis in HFD-induced obese mice by the inhibition of lipogenesis through modulation of the AMPK–SREBP1c signaling pathway [30].